Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 5;30(5):103082.
doi: 10.1016/j.jaccas.2024.103082.

Beyond Eyes and Ears: Inflammation Provoking Infarction in Cogan Syndrome

Paul M Haller  1 , Brian A Bergmark  2
Affiliations
Editorial

Beyond Eyes and Ears: Inflammation Provoking Infarction in Cogan Syndrome

Paul M Haller et al. JACC Case Rep. .
No abstract available

Keywords: acute coronary syndrome; left main coronary artery; percutaneous coronary intervention; vasculitis.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Haller is supported by the German Research Foundation. Dr Bergmark has received grant support through his institution from Ionis, Pfizer, Abbott Vascular, Philips, Inari, AstraZeneca, MedImmune, and Amgen; has received consulting and personal fees from Boston Scientific, Shockwave Medical, Abbott Vascular, Abiomed, Bain Life Sciences, Bolt, Terumo, SpectraWAVE, Cardiovascular Systems, and Endovascular Engineering. Drs Haller and Bergmark are members of the TIMI Study Group, which has received grant support through Brigham and Women’s Hospital from Abbott Laboratories, Abiomed, Amgen, Anthos Therapeutics, ARCA Biopharma, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Ionis Pharmaceuticals, Janssen Research and Development, MedImmune, Merck, Novartis, Pfizer, Regeneron Pharmaceuticals, Roche, Saghmos Therapeutics, Siemens Healthcare Diagnostics, Softcell Medical, The Medicines Company, Verve Therapeutics, and Zora Biosciences.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jaccas.2024.103080

References

    1. Khanna S., Garikapati K., Goh D.S.L., et al. Coronary artery vasculitis: a review of current literature. BMC Cardiovasc Disord. 2021;21:7. - PMC - PubMed
    1. Lin Z., Jia L., Yin D., et al. Current evidence in the diagnosis and management of coronary arteritis presenting as acute coronary syndrome. Curr Probl Cardiol. 2023;48 - PubMed
    1. Giovacchini J., Cappelli F., Tomberli B., et al. Managing complex coronary revascularization of acute coronary syndrome during cogan syndrome. JACC Case Rep. 2025;30(5) - PubMed
    1. Kessel A., Vadasz Z., Toubi E. Cogan syndrome—pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2014;13:351–354. - PubMed
    1. McCrindle B.W., Rowley A.H., Newburger J.W., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–e999. - PubMed

Publication types

LinkOut - more resources